ACCL vs ENSG vs NHC vs ACCO

For growth investors, The Ensign Group, Inc.

(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus -8. 5% for ACCO Brands Corporation (ACCO). ACCO Brands Corporation (ACCO) offers the better valuation at 8. 9x trailing P/E (4. 5x forward), making it the more compelling value choice. Analysts rate The Ensign Group, Inc. (ENSG) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, ACCO Brands Corporation (ACCO) is the cheapest at 8.

9x versus Acco Group Holdings Limited Ordinary Shares at 160. 4x. On forward P/E, ACCO Brands Corporation is actually cheaper at 4. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: National HealthCare Corporation wins at 1. 03x versus The Ensign Group, Inc. 's 1. 69x — a reasonable growth-adjusted valuation.

Over the past 5 years, National HealthCare Corporation (NHC) delivered a total return of +185.

4%, compared to -64. 0% for Acco Group Holdings Limited Ordinary Shares (ACCL). Over 10 years, the gap is even starker: ENSG returned +815. 2% versus ACCL's -64. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 38β versus ACCO Brands Corporation's 1. 35β — meaning ACCO is approximately 256% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Acco Group Holdings Limited Ordinary Shares (ACCL) carries a lower debt/equity ratio of 7% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Ensign Group, Inc.

(ENSG) is pulling ahead at 18. 7% versus -8. 5% for ACCO Brands Corporation (ACCO). On earnings-per-share growth, the picture is similar: ACCO Brands Corporation grew EPS 141. 5% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Acco Group Holdings Limited Ordinary Shares (ACCL) is the more profitable company, earning 22.

7% net margin versus 2. 7% for ACCO Brands Corporation — meaning it keeps 22. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACCL leads at 24. 2% versus 7. 1% for ACCO. At the gross margin level — before operating expenses — NHC leads at 67. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, National HealthCare Corporation (NHC) is the more undervalued stock at a PEG of 1. 03x versus The Ensign Group, Inc. 's 1. 69x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, ACCO Brands Corporation (ACCO) trades at 4. 5x forward P/E versus 23. 8x for National HealthCare Corporation — 19. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACCO: 104. 1% to $8. 00.

In this comparison, ACCO (7.

3% yield), NHC (1. 3% yield), ENSG (0. 1% yield) pay a dividend. ACCL does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Ensign Group, Inc.

(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), +815. 2% 10Y return). Both have compounded well over 10 years (ENSG: +815. 2%, ACCO: -37. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ACCL (Industrials) and ENSG (Healthcare) and NHC (Healthcare) and ACCO (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ACCL is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; NHC is a small-cap high-growth stock; ACCO is a small-cap deep-value stock. NHC, ACCO pay a dividend while ACCL, ENSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.